Skip to Main Content

Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)

Conditions

Aging | Diseases of the Musculoskeletal System

Phase III

What is the purpose of this trial?

Brief Summary:

The objectives of this study are to assess the efficacy, safety, and tolerability of PLX-PAD intramuscular administration for the treatment of muscle injury following arthroplasty for HF.

  • Trial with
    Pluristem Ltd.
  • Start Date
    09/21/2018
  • End Date
    06/30/2020
Trial Image

For more information about this study, contact:

Jeanine May

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    01/17/2019
  • Study HIC
    #2000023630